Maxcyte (MXCT) EBT Margin Growth (3y) (2023 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -305.00
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -9.00
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -222.00
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 923.00
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -480.00
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 2,114.00
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 1,391.00
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -176.00
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 329.00
10 Maxcyte 129.85 Mn 129.85 Mn 8.08 Mn 17,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 17,000.00
Dec 31, 2025 4,556.00
Sep 30, 2025 -9,186.00
Jun 30, 2025 -12,620.00
Mar 31, 2025 -14,357.00
Dec 31, 2024 -34,646.00
Sep 30, 2024 -9,377.00
Jun 30, 2024 -12,665.00
Mar 31, 2024 -297.00
Dec 31, 2023 15,786.00
Sep 30, 2023 -20,435.00
Jun 30, 2023 1,289.00